Compare Mutual Funds

Pros
Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
10/11
Category

Equity, Sector - Healthcare

Fund Age

14 Years

Fund AUM

₹9166 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1%

Exit Load

1%

Benchmark Index

BSE Healthcare TR INR

No of Holdings

40

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.71%)
  2. Divi's Laboratories Ltd(7.1%)
  3. Lupin Ltd(6.17%)
  4. Cipla Ltd(6.01%)
  5. Dr Reddy's Laboratories Ltd(5.45%)
No of Sectors

1

Top 3 Sectors

Health

(100%)

Equity %

97.3%

Debt %

-

P/E

37.98

P/B

5.6

Credit Quality

-

Modified Duration

-

YTM

-

1-Month Return

8.35%

3-Month Return

3.22%

6-Month Return

9.83%

1-Year Return

16.1%

3-Year Return

18.88%

5-Year Return

15.31%

Sharpe

0.83

Alpha

-2.19

Beta

0.89

Standard Deviation

14.87

Information Ratio

-1.14

Description

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Amber Singhania, Sailesh Raj Bhan, Kinjal Desai

Most Popular Comparisons